Polyclonal Rabbit anti‑Human KIAA0652 / ATG13 Antibody (Atto 390, IF, WB) LS‑C773984
Polyclonal Rabbit anti‑Human KIAA0652 / ATG13 Antibody (Atto 390, IF, WB) LS‑C773984
Antibody:
KIAA0652 / ATG13 Rabbit anti-Human Polyclonal (Atto 390) Antibody
Format:
Atto 390, Unmodified
Overview
Antibody:
KIAA0652 / ATG13 Rabbit anti-Human Polyclonal (Atto 390) Antibody
Format:
Atto 390, Unmodified
Specifications
Description
ATG13 antibody LS-C773984 is an Atto 390-conjugated rabbit polyclonal antibody to ATG13 (KIAA0652) from human. It is reactive with human and mouse. Validated for IF and WB.
Target
Human KIAA0652 / ATG13
Synonyms
ATG13 | Autophagy-related protein 13 | KIAA0652 | Autophagy related 13
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Atto 390.
Also available conjugated with
APC,
Atto 488,
Atto 565,
Atto 594,
Atto 633,
Atto 655,
Atto 680,
Atto 700,
Biotin,
FITC,
HRP,
PE, Atto 594,
PerCP,
RPE,
SA.
Purification
Peptide Affinity Purified
Immunogen
Synthetic peptide from the mid-protein range of human ATG13
Specificity
Detects ~56-63 kDa.
Applications
- Immunofluorescence (1:100)
- Western blot (1:1000)
- Applications tested for the base form of this product only
Usage
Applications should be user optimized.
Presentation
PBS, 0.09% Sodium Azide, 50% Glycerol
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Species:
Human
Applications:
Western blot, Flow Cytometry, ELISA
Species:
Human, Mouse
Applications:
Immunofluorescence, Western blot
Species:
Human
Applications:
Western blot, Flow Cytometry, ELISA
Species:
Human, Mouse, Rat
Applications:
IHC, Immunofluorescence, Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/21/2024